Leslie Mertz (firstname.lastname@example.org) is a freelance science, medical, and technical writer, author, and educator living in northern Michigan.
Slip on a set virtual reality (VR) goggles and connected gloves, and you are transported to another world. For the entertainment industry, that kind of immersive VR may mean shoot-‘em-up games where players have to blast blood-thirsty aliens or other bad guys to save the
Back in the mid-1960s, rotary-dial telephones were the norm, music cassette tapes were brand new, and microwave ovens hadn’t made it into houses yet. That’s also when newly minted electrical engineer Thomas Furness joined a U.S. Air Force Lab and began developing what would become
For people who have relied on good eyesight for the first six or seven decades of their lives, the diagnosis of age-related macular degeneration (AMD) is devastating. This disease, which currently has no cure, can severely limit central vision and, in many cases, may culminate in legal blindness (unable to see the Big E on the eye chart; vision less than 20/200). Early results from two new stem-cell trials, however, suggest that this type of treatment may be able to restore sight in people with both the dry and wet forms of AMD.
Until a dangerous bacterial infection left her husband near death 3 years ago, scientist Steffanie Strathdee had never heard of bacteriophage therapy. After it ultimately saved his life, however, she not only has become a staunch advocate of the therapy, but also now serves as co-director of the newly established Center for Innovative Phage Applications and Therapeutics at the University of California San Diego.
Only a few years ago, leading autism expert David Amaral described the disorder as a lifelong disability. Today, he acknowledges that description is no longer true. “Research lately shows that a substantial proportion of children with autism spectrum disorder (ASD) show really substantial improvements in their autism symptoms,” says Amaral.
When an artery is blocked, stents are often the best way to open up the vessel. A mesh stent is tightly crimped over a tiny balloon and guided to the troubled spot; the balloon is inflated, expanding the stent, which forces the vessel open. Blood flow is restored.
Innovative researchers are employing flexible, rather than rigid materials in combination with new design approaches as part of the emerging field of biomedical soft robotics. The idea is to generate tools that conform to and interact with the human body in a much more natural and lightweight way, providing better treatment options for clinicians and translating into better outcomes for patients.
Work is already underway to bring blockchain technology to the healthcare industry, and hospital administrators are trying to figure out what it can do for them, their clinicians, and their patients. That includes administrators at Beth Israel Deaconess Medical Center, a leading academic medical center located in Boston. We interviewed the medical center’s chief information officer (CIO), John D. Halamka, M.D.
A blockchain revolution sweeps into health care, offering the possibility for a much-needed data solution.
Nuclear medicine has come a long way in a short time. Over the past three decades alone, it has taken two major steps forward and is now on the precipice of yet another advance that could begin to have a real impact on cancer care within the year.